Pfizer Inc
- SEC CIK
- 0000078003
- Latest filing
- Aug 13, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 11, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 21
- 0 vs. Q1 2025
- Portfolio value
- $576.2M
- +$75.4M (+15.0%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BNTXBioNTech SE | SPONSORED ADS | 3,658,361 | $389.5M | 67.6% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 5,376,344 | $54.6M | 9.5% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 3,457,815 | $25.4M | 4.4% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 22,032,040 | $24.9M | 4.3% | 00.0% | Unchanged | History |
| TRMLTourmaline Bio, Inc. | COM | 1,272,214 | $20.3M | 3.5% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 1,875,000 | $12.2M | 2.1% | 00.0% | Unchanged | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 7,032,770 | $7.74M | 1.3% | 00.0% | Unchanged | History |
| CRDFCardiff Oncology, Inc. | COM | 2,411,575 | $7.60M | 1.3% | 00.0% | Unchanged | History |
| BHVNBiohaven Ltd. | COM | 505,645 | $7.13M | 1.2% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 2,362,348 | $6.85M | 1.2% | 00.0% | Unchanged | History |
| CRBUCaribou Biosciences, Inc. | COM | 4,690,431 | $5.91M | 1.0% | 00.0% | Unchanged | History |
| CELCCelcuity Inc. | COM | 349,406 | $4.66M | 0.8% | 00.0% | Unchanged | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 2,970,022 | $3.12M | 0.5% | 00.0% | Unchanged | History |
| EPIXESSA Pharma Inc. | COM NEW | 1,675,000 | $2.85M | 0.5% | 00.0% | Unchanged | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 953,834 | $1.11M | 0.2% | 00.0% | Unchanged | History |
| NXTCNextCure, Inc. | COM | 157,646 | $870.2K | 0.2% | −1,734,117−91.7% | Reduced | History |
| ANTXAN2 Therapeutics, Inc. | COM | 715,295 | $758.2K | 0.1% | 00.0% | Unchanged | History |
| QTTBQ32 Bio Inc. | COM | 277,777 | $413.9K | 0.1% | 00.0% | Unchanged | History |
| BOLTBolt Biotherapeutics, Inc. | COM NEW | 31,305 | $180.6K | <0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | History |
| DNAGinkgo Bioworks Holdings, Inc. | CL A NEW | 2,928 | $32.9K | <0.1% | 00.0% | Unchanged | History |
| SENSSenseonics Holdings, Inc. | COM | 43,426 | $20.7K | <0.1% | 00.0% | Unchanged | History |